Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial - Test2 - elhamkhani - TriplyDB

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

http://www.wikidata.org/entity/Q24607545

about

DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models The emerging role of dietary fructose in obesity and cognitive decline Nutrition and the risk of Alzheimer's disease Omega-3 fatty acids for the treatment of dementia Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2 Nutritional Factors Affecting Mental Health Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer Effects of Physical Exercise Combined with Nutritional Supplements on Aging Brain Related Structures and Functions: A Systematic Review.Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease Docosahexaenoic Acid and Cognition throughout the Lifespan Components of a Mediterranean diet and their impact on cognitive functions in aging Oxidative Stress in Neurodegenerative Diseases Identifying and characterizing the effects of nutrition on hippocampal memory Importance and management of micronutrient deficiencies in patients with Alzheimer's disease Bioavailability of bioactive food compounds: a challenging journey to bioefficacy A practical algorithm for managing Alzheimer's disease: what, when, and why?Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment ω-3 fatty acid supplementation as a potential therapeutic aid for the recovery from mild traumatic brain injury/concussion Practical diagnosis and management of dementia due to Alzheimer's disease in the primary care setting: an evidence-based approach Cancer nanotechnology: emerging role of gold nanoconjugates Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization Effects of Omega-3 Fatty Acid Supplementation on Cognitive Functions and Neural Substrates: A Voxel-Based Morphometry Study in Aged Mice.Combining pain therapy with lifestyle: the role of personalized nutrition and nutritional supplements according to the SIMPAR Feed Your Destiny approach Effects of N-3 Polyunsaturated Fatty Acids on Dementia Impact of Genotype on EPA and DHA Status and Responsiveness to Increased Intakes Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer's Disease Docosahexaenoic acid (DHA): a modulator of microglia activity and dendritic spine morphology Omega-3 Use in Psychiatry: Evidence-Based or Elegance-Based?Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.Dietary supplements and disease prevention - a global overview.Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.Brain imaging and human nutrition: which measures to use in intervention studies?Rationale and clinical data supporting nutritional intervention in Alzheimer's disease.Imaging endpoints for clinical trials in Alzheimer's disease.The Use of Neuroimaging to Assess Associations Among Diet, Nutrients, Metabolic Syndrome, and Alzheimer's Disease.The role of nutrition on cognition and brain health in ageing: a targeted approach.Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.Effects of Long-Chain Omega-3 Polyunsaturated Fatty Acids on Endothelial Vasodilator Function and Cognition-Are They Interrelated?

P2860

Q21135531-D561CF17-234D-49AF-B626-929D282F4D03 Q21135583-F90FC635-94F0-4C8E-9F05-8E99261151DB Q21245916-603FB679-3975-4C4D-8CE2-859029AB8AAB Q22241959-E01A9BB6-E7BF-4C92-8D6D-4C62E447EB35 Q24185910-AD5921CE-FFE8-4E20-9CBE-9DE2DF1F9BB8 Q24314295-69314C44-430F-4D99-B055-3650829E598B Q26740031-A14DFEE4-4785-40E1-B0C9-CA0369155EC1 Q26741524-0A17845C-698B-4438-A697-8C381591B2AE Q26741607-E22742D5-2C61-41BA-B739-41FD0B719206 Q26766462-5F4FE828-A258-4B16-AD7D-3A847D3FCDF5 Q26768442-F0EB5906-8528-496E-9907-5CAF8DEC7B00 Q26798765-92B10FE8-8EFA-4E9D-A2F9-96F391FFEBF3 Q26801239-4A97C859-98F7-46AE-BF51-60DBF0FD0A1F Q26825039-CE01DF98-320B-4F30-9970-A2F21316A3C4 Q26852673-965CC0A3-799B-4C06-964E-FA740D77C5DB Q26853534-06CC5888-B3FD-4AB8-8A9E-EB2D67B56705 Q26859831-63CEB3A2-2DD1-486E-A53A-D0683AF6B573 Q26860246-DA22745F-503A-4F64-9D79-BCB5118DAD23 Q26991937-4CA9A887-26FF-4F10-844A-83E8158582A8 Q27006895-857A83C7-1849-4E1B-8E14-22D4E114C8D6 Q27021820-633B269A-0DF1-4D80-BC91-05298C9A0BC2 Q27307991-7CA8AB52-E1B0-43EC-9660-424A81C2836B Q27323288-1FB25B8D-DFC8-44BA-B1B5-FCBE67E8585F Q28068212-E7AEECBE-6645-446D-8711-697A75163E23 Q28075307-02101168-9E85-4D7F-8EF9-06E25AF3E7BC Q28077212-A90C5727-085A-491F-B252-BD3CCAA30E3E Q28080464-CF549133-BF9B-4827-A88C-A8B0D608443A Q28388907-5E50495A-4B45-41B6-A6FE-844A8FE00E73 Q30101111-242AA151-6766-4EEA-93FD-5D5D1FBC554B Q30238885-D9EF1278-1182-42B8-8C2F-EE0BECF4C0E8 Q30251418-5138ADD9-7DD2-4829-91ED-13072174F4C2 Q30616078-905BC8F4-0F43-44CE-A147-E1CE8FB98736 Q30658391-651BA976-FEC6-4BF6-A0CF-6D240BDA7243 Q30779251-8562F589-FAF0-4BF0-A322-D809D2EA1A02 Q30885979-B334CD5A-2687-4372-A222-A1B77BF19069 Q30996713-A9589692-A701-43D5-AFD6-5A23F35126EB Q31031167-79619CE1-BF7A-4FFE-8F0D-00FE3FDD55BA Q33639450-1116CDA1-7790-40C8-8ADF-237E13DCFFE0 Q33745617-E2EDBBFA-1A39-49B2-9A53-4B4DD5C0CB10 Q33749456-46641054-D09E-4483-8A5D-AA8A5E972A52

P2860

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

http://www.wikidata.org/entity/Q24607545

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Docosahexaenoic acid supplemen ...... er disease: a randomized trial

@ast

Docosahexaenoic acid supplemen ...... er disease: a randomized trial

@en

Docosahexaenoic acid supplemen ...... er disease: a randomized trial

@nl

type

label

Docosahexaenoic acid supplemen ...... er disease: a randomized trial

@ast

Docosahexaenoic acid supplemen ...... er disease: a randomized trial

@en

Docosahexaenoic acid supplemen ...... er disease: a randomized trial

@nl

prefLabel

Docosahexaenoic acid supplemen ...... er disease: a randomized trial

@ast

Docosahexaenoic acid supplemen ...... er disease: a randomized trial

@en

Docosahexaenoic acid supplemen ...... er disease: a randomized trial

@nl

P1433

Q24607545-F25815B7-F40C-49DA-A103-B4C7D4276C08

P1476

Q24607545-00AC8523-135C-4405-893B-85D0B0C47B8A

P2093

Q24607545-0495F8B7-DCEA-412D-A31C-E4E8741266AB

Q24607545-2A74204F-0D04-4977-8180-C4508A4000DD

Q24607545-464CC4CA-8DDC-41BE-AB31-F2EDD579C541

Q24607545-4FFDBB4D-B12C-47A2-8956-134480E14363

Q24607545-820D6267-35FE-45F8-89AB-63F3BD851BE5

Q24607545-82A41FA0-C446-412C-A237-C5C3EAF997C2

Q24607545-B25969FC-AB85-49E5-AB6B-694CD8CC8FED

Q24607545-B42F11DD-EE68-450B-9F46-18A8DF9EB4D4

Q24607545-CF15424F-FD47-453F-8CEE-67D9724A3F76

Q24607545-F77053BB-57BF-47E1-A210-978B123EB242

P2860

Q24607545-0004D9B9-B715-4E39-8A92-FCE2FDFED969

Q24607545-0B72E039-2169-47E3-8C01-A5A4A3C22FBD

Q24607545-12529391-F9A1-42D0-9935-7D0B908F5928

Q24607545-184181AD-FA1F-479A-B504-6C7AA983E0BC

Q24607545-1A027FD8-C5EA-4CC7-B85B-7AFFBBCEEABA

Q24607545-22D18C27-A3CF-46EF-958F-12D316A1944E

Q24607545-2A5907DB-173C-4A56-BA2F-4783B840030B

Q24607545-39FEC801-6714-430E-8F1E-86395D15F4EE

Q24607545-3C5E9558-F85D-457A-A9CF-A8855B97C8D1

Q24607545-414D0518-20C0-4B7C-BB81-115D9B24AFEC

P304

Q24607545-452D02AC-2600-4A26-83BD-514F8EAF58A0

P31

Q24607545-31816A85-3348-4FCA-9915-34E938AF50CA

P3181

Q24607545-13349EE8-3BAF-494E-8658-CC29314ACE96

P356

Q24607545-DEFD17B0-3AF9-429F-8699-CB7F57265A35

P407

Q24607545-28020A04-3BBD-441E-80AB-E3C9DB607FB9

P433

Q24607545-1EC4BACD-C692-45F8-BD34-8912FBCA4FF7

P478

Q24607545-14EA3FA0-D41C-44B4-A5F9-A99C547994B0

P50

Q24607545-117B1B0D-B7C8-4036-A217-B5B98FB0D843

Q24607545-5181AA42-2CFD-46BC-BCF7-09EBAB42EA47

P577

Q24607545-641F828A-7FC7-457B-8BC4-F3B1AFB202E9

P5875

Q24607545-0C8C727B-EF13-4619-B369-C58A1F85A62B

P698

Q24607545-1461F01A-47E7-4500-82B1-12BBEFD4D433

P921

Q24607545-C7E17843-F079-45FC-9E1E-953BF9B5221A

Q24607545-F741289A-86FF-495B-BCB1-251A4171FDD9

P932

Q24607545-3DA9AE31-3795-4107-996D-704B257C78C6

P3181

P356

P1433

Journal of the American Medical Association

P1476

Docosahexaenoic acid supplemen ...... er disease: a randomized trial

@en

P2093

Christopher Van Dyck

http://www.w3.org/2001/XMLSchema#string

Edward B Nelson

http://www.w3.org/2001/XMLSchema#string

James E Galvin

http://www.w3.org/2001/XMLSchema#string

Jennifer Emond

http://www.w3.org/2001/XMLSchema#string

Joseph F Quinn

http://www.w3.org/2001/XMLSchema#string

Karin Yurko-Mauro

http://www.w3.org/2001/XMLSchema#string

Lynne Shinto

http://www.w3.org/2001/XMLSchema#string

Michael Weiner

http://www.w3.org/2001/XMLSchema#string

Rema Raman

http://www.w3.org/2001/XMLSchema#string

Ronald G Thomas

http://www.w3.org/2001/XMLSchema#string

P2860

Omega 3 fatty acid for the prevention of dementia

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

“Mini-mental state”

The Clinical Dementia Rating (CDR): current version and scoring rules

Enhanced level of n-3 fatty acid in membrane phospholipids induces lipid peroxidation in rats fed dietary docosahexaenoic acid oil.

MRI substudy participation in Alzheimer disease (AD) clinical trials: baseline comparability of a substudy sample to entire study population

Fish, meat, and risk of dementia: cohort study.

Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease.

Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.

Dietary fat intake and the risk of incident dementia in the Rotterdam Study.

P304

1903-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

336393

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/JAMA.2010.1510

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

304

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47661027

http://www.w3.org/2001/XMLSchema#string

P698

21045096

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3259852

http://www.w3.org/2001/XMLSchema#string